Global Pharmaceutical Isolator Market Size (2024 - 2029)

Pharmaceutical Isolator Market Analysis

The Pharmaceutical Isolator Market is projected to register a CAGR of 10% during the forecast period (2022-2027).

The coronavirus outbreak increased the demand for pharmaceuticals, resulting in the growth of the pharmaceutical isolator market during the pandemic. For instance, as per an article published in July 2020, titled' Short and Long Term Impact of COVID-19 on the Pharmaceutical Sector' mentioned that COVID-19 increased the demand for prescription medicines, vaccines, and medical devices. Such studies prove the increase in demand for pharmaceutical isolators in the pharmaceutical industry. Moreover, the companies are performing clinical trials to curb the spread of the COVID-19 virus. For instance, Comecer developed the VaxISO Upstream isolator, the new dedicated stand-alone isolator for vaccine research and final formulation. Thus, increased clinical trials will lead to vital opportunities for the pharmaceutical isolator providers for biopharmaceutical companies.

Major factors such as greater sterility assurance of the pharmaceutical isolators are expected to drive the market's growth during the forecast period. The immense sterility assurance of pharmaceutical isolators results in expanding the market demand. The preparations of the pharmaceutical manufacturing process include the inclusion of Active pharmaceutical ingredients with high potency, which require extreme caution and sterile environments assuring the contents from contamination. The pharmaceutical isolator satisfies the needs of the sterile environment n the manufactured process and delivers the desired finished product.

Moreover, increase in research and development expenditure in pharmaceutical research the market is expected to see a surge over the forecast period. For instance, according to the Pharmaceutical Research and Manufacturers of America data updates from September 2021, since 2000, PhRMA member companies have invested more than USD 1.1 Trillion in the search for new treatments and cures, including USD 102.3 Billion in 2021 alone. Furthermore, these are expected to increase further over the forecast period.

Moreover, as per an article published by Inos in May 2020, titled 'Benefits of Aseptic Isolators', positive pressure is maintained in the isolator to ensure that particles from the setup room will not enter the isolator and contamination does not take place. Aseptic isolators are routinely found within the pharmaceutical industry and are widely used for sterile injectable drug filling and sterile & pharmacy drug compounding. Thus, the advantage provided by the pharmaceutical isolators is expected to increase the adoption of pharmaceutical isolators over the forecast period.

The increasing innovative launches by the market players to meet the growing demand of the end users is expected to boost the growth of the market. For instance, in April 2021, ILC combined Solo's rich history in single-use isolators with its expertise in flexible powder handling solutions. Moreover, in April 2021, ILC Dover launched a flexible aseptic isolator soloPURE for pharma and biopharma processing. ILC Dover brings one such solution to the table in the form of its fully disposable, single-use chamber and CAPEX-efficient soloPURE. The flexible aseptic isolator is a cost-effective, closed-barrier system for sterile manufacturing. Therefore, the above factors are expected to drive the market's growth.

However, the availability of alternatives is expected to hinder market growth.

Pharmaceutical Isolator Industry Segmentation

As per the scope of the report, Pharmaceutical isolators in the pharmaceutical industry are used to handle drugs, materials, and quality control processes in a system that offers complete isolation from the surrounding environment and the personnel processing these materials. The Pharmaceutical Isolator Market is segmented by Type (Closed Isolator Systems and Open Isolator Systems), Application (Aseptic Isolators, Containment Isolators, and Others), End-user (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others), and Geography (North America, Europe, Asia-pacific, middle east, Africa, and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values (in USD million) for the above segments.